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Abstract
Atomic Force Microscopy was utilized to study the morphology of Gag, ΨRNA, and their binding
complexes with lipids in a solution environment with 0.1Å vertical and 1nm lateral resolution. TARpolyA
RNA was used as a RNA control. The lipid used was phospha-tidylinositol-(4,5)-bisphosphate (PI(4,5)P2).
The morphology of specific complexes Gag-ΨRNA, Gag-TARpolyA RNA, Gag-PI(4,5)P2 and
PI(4,5)P2-ΨRNA-Gag were studied. They were imaged on either positively or negatively charged mica
substrates depending on the net charges carried. Gag and its complexes consist of monomers, dimers and
tetramers, which was confirmed by gel electrophoresis. The addition of specific ΨRNA to Gag is found to
increase Gag multimerization. Non-specific TARpolyA RNA was found not to lead to an increase in Gag
multimerization. The addition PI(4,5)P2 to Gag increases Gag multimerization, but to a lesser extent than
ΨRNA. When both ΨRNA and PI(4,5)P2 are present Gag undergoes comformational changes and an even
higher degree of multimerization.
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21 Introduction
Human immunodeficiency virus (HIV) is a retrovirus with a diploid genome of single-stranded RNA
[1-4]. Two types of HIV, HIV-1 and HIV-2, have been reported [5]. HIV-1 is contagious and more virulent
than HIV-2. Therefore, primary studies are focused on HIV-1. HIV is a spherical membrane-bound virus
with a diameter ranging from 100 nm to 150 nm. It initially buds from the plasma membrane of infected
host cells as a noninfectious immature virion [1-4]. The formation of infectious HIV is considered to have
three stages: (1) assembly, (2) budding and release, and (3) maturation [1, 6-8]. The first stage is the
assembly where critical components are encapsulated to create an immature virion at the lipid plasma
membrane. The second stage is the budding and release, where the immature virion acquires the necessary
lipids to form its envelope and buds from the plasma membrane. The last stage is the maturation where the
immature virion undergoes conformational changes to form a mature infectious virus. The most important
structural component of HIV is the genetic polyprotein precursor Gag, the group specific antigen, which is
involved in all of the three stages of HIV virion formation. The HIV immature virion has approximately
2500-5000 copies of the Gag polyprotein [1, 3]. The approximate mass of Gag is 55kDa [8]. Extended Gag
is thought to have a cylindrical shape with a length of 20-30nm and a diameter of 2-3nm [2]. From
N-terminus to C-terminus, Gag consists of six structural domains: a matrix (MA) domain with
amino-terminal myristylation (Myr), a capsid (CA) domain, spacer peptides 1 (SP1), a nucleocapsid (NC)
domain, spacer peptides 2 (SP2), and a p6, respectively [1, 6,7, 9]. The three primary functional domains of
the Gag are MA, CA and NC. The HIV Gag precursor in the immature virion is radially oriented [1]. The
N-terminal MA domain is bound to the inner leaflet of the lipid membrane. The C-terminal NC domain
binds with two copies of viral genomic RNA. The central CA domain interacts with each other forming a
hexagonal lattice. Gag serves as the bridge to connect the lipid membrane and dimeric viral RNA and forms
a scaffold with other Gags to support the structure of the immature HIV virion. In later stages, the immature
HIV virion becomes mature via proteolysis with the help of a viral protease that cleaves the Gag in a
specific order as discussed in Ref. [10].
The N-terminal MA domain of HIV-1 Gag encompassing 104 amino acids exhibits five alpha helices
and a triple-stranded beta sheet [11-13]. MA has a myristoylated fatty acid group at its N-terminus which is
responsible for Gag assembly and targets to the phospha-tidylinositol-(4,5)-bisphosphate (PI(4,5)P2) on the
lipid membrane [14,15]. The 14-carbon myristoylated group is initially sequestered in a hydrophobic cleft
in the MA domain, which is later exposed to facilitate Gag binding with the lipid membrane. The exposure
of the myristyl acid group is triggered by PI(4,5)P2 which is abundant in the lipid plasma membrane. The
central CA domain of HIV Gag is responsible for the adjacent Gag-Gag interaction. The CA domain is
separated into two parts, the N-terminal domain (CANTD) and the C-terminal domain (CACTD) connected by
a flexible linker. The arrowhead-like shaped CANTD containing seven alpha helices is essential for the
formation of a conical outer shell of the capsid core [16, 17]. The CANTD forms hexameric rings with an
approximate spacing of around 8 nm as observed with cryo-electron microscopy (cET) [18, 19]. The CANTD
also forms pentameric rings, which are not necessary for the formation of immature virions but are
indispensable for the formation of the closed shell of the core that adopts a fullerene cone structure in the
mature virus. The CA domain plays a vital role in the formation of both immature and mature virions. In
the mature virus, the mature capsid core consists of 1000-1500 copies of the CA protein assembled into a
3hexameric lattice with a spacing of 10 nm rather than 8nm which is the spacing of CA hexamers in the
immature virions [3]. Therefore the CA hexamers must be rearranged during the final stage of maturation.
Although the NC domain is the smallest component of HIV Gag compared to MA and CA domains, it is
critical for the genomic viral RNA recognition, interaction and dimerization. The NC domain tethers Gag to
the RNA genome through nonspecific interaction as well as specific binding to the stem-loop 3 (SL3) in the
packaging signal Ψ (ΨRNA) [20]. In the inner core of the mature virus, the viral genomic RNA is wrapped
around 1500-2000 copies of NC proteins [21]. Within the NC domain, there are two CCHC type zinc
fingers, which are crucial for specific ΨRNA binding and genomic viral RNA packaging [22, 23]. The
spacing distance between two zinc fingers is highly conserved which is essential for NC functions [24].
HIV-1 genome is principally a sequence of RNA that consists of 9173 nucleotides (~9kb) [9, 25]. It is
involved in many activities throughout the virus replication cycle, such as expressing transcription,
facilitating genomic dimerization and transportation, signaling polyadenylation, mediating HIV genome
packaging, initiating reverse transcription etc. HIV-1 genome is always packed into the virion as an RNA
dimer, i.e. two copies of full length ~9kb RNA, which is 5’ capped and 3’ polyadenylated. At the 5’
untranslated region (UTR) of HIV-1 genomic RNA, there are a variety of critical regions which are
considered necessary for genome dimerization and binding with Gag: the transactivation response
stem-loop (TAR), the polyadenylation stem-loop (polyA), the prime binding site (PBS) and the packaging
signal domain Ψ. Of the 104 nucleotides of HIV viral RNA, the first 1-57 nucleotides is TAR with 58-104
nucleotides being polyA [26, 27]. The mass of the TARpolyA RNA is around 34kDa. The TARpolyA RNA
sequence used in the experiments is shown in Fig.1(a) [22]. It plays an essential role in HIV genome
packaging and reverse transcription [26]. Small-angle X-ray scattering (SAXS) studies have shown TAR
and polyA hairpins extend into a stable coaxially stacked helices [26]. In addition to the dimerization
initiation site (DIS) in Ψ, the TAR may also facilitate HIV genomic RNA dimerization only when the NC
protein is present. This is because the exposure of the hidden palindromic sequence in the TAR hairpin
requires the NC protein to form TAR-TAR dimers [28]. The packaging signal Ψ contains approximately
109 nucleotides [26, 29]. The mass of the ΨRNA is about 36kDa. The ΨRNA sequence used in our work is
shown in Fig.1(b) where most of nucleotides are paired with each other [26]. It contains 3 stem loops SL1,
SL2, and SL3. SAXS studies have revealed ΨRNA adopts an unfolded conformation where all stem loops
are open for later interaction with both viral and host elements. The ΨRNA binds with the NC protein and
is crucial for packaging of HIV genomic RNA into the virus. Within the ΨRNA, SL1 contains a
palindromic sequence DIS that is responsible for HIV genomic RNA dimerization and Gag binding at the
early stages of HIV virus replication cycle [30-32]. SL2 includes the splice donor site (SD) that is used to
produce all subsequent spliced message RNAs (mRNA) for production and translation of viral accessory
proteins. SL3 is required for both viral RNA dimerization and packaging [33]. In addition to SL1, SL3 is
also an independent high affinity Gag binding site [34].
PI(4,5)P2 belongs to the negatively charged lipid family known as phosphoinositide [35]. It consists of
a glycerol backbone with one saturated fatty acid chain at position 1’ and one unsaturated fatty acid chain at
position 2’ and a phosphoinositol headgroup at position 3’. PI(4,5)P2 is an important component of the host
cell membrane and is enriched at the cytoplasmic leaflet of the plasma membrane. It also serves as a raft for
HIV-1 Gag targeting to the plasma membrane and regulates the HIV assembly [35, 36]. More specifically,
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First, the phosphoinositol headgroup and the 2’ unsaturated fatty acid chain of PI(4,5)P2 insert into a
hydrophobic pocket in the MA domain. This then triggers the exposure of the myristylated group for
insertion into the lipid bilayer membrane [37-40]. The 1’ saturated fatty acid chain serves as an anchor for
Gag targeting to plasma membrane although it does not interact with the MA domain. Therefore, there are
two saturated fatty acid chains anchoring Gag-membrane binding, and one is the myristylated group from
the MA domain and the other is the 1’ saturated fatty acid chain from PI(4,5)P2 [1].
Previous research has suggested that Gag has distinct binding modes with different RNAs [22]. For
non-specific TARpolyA RNA, both the NC and MA domains are bound to TARpolyA RNA. While in the
case of specific ΨRNA, only the NC domain was found to bind with ΨRNA [22]. In the latter case, MA
domain is left free for later interaction with lipid PI(4,5)P2. The motivation of this work is to utilize a
high-resolution technique such as Atomic Force Microscopy (AFM) to explore HIV-1 Gag binding with
different RNAs and lipids. First, we studied the morphology of individual components of Gag, ΨRNA, and
TARpolyA RNA separately as controls. Next, to see the effect of the addition of specific and non-specific
RNAs, we investigated the effect on the complex formation by adding either ΨRNA or TARpolyA RNA to
Gag. Then, the effect of adding lipid PI(4,5)P2 into Gag was also studied. Finally, the effect of the addition
of both ΨRNA and PI(4,5)P2 was examined to understand their collective effect on Gag.
2 Materials and methods
2.1 Materials
HIV-1 Gag used in our experiments was obtained from Dr. Alan Rein and Dr. S.A.K. Datta. It lacks the
myristylated group and p6 and thus usually is referred to as GagΔP6 [22]. Both ΨRNA and TARpolyA
RNA were obtained from Dr. Karin Musier-Forsyth and Dr. E.D. Olson [36]. Brain PI(4,5)P2
(L-α-phosphatidylinositol-4,5-bisphosphate) was purchased from Avanti Polar Lipids (Alabaster, AL, US).
2.2 Preparation of samples
HIV-1 GagΔP6 was originally at 30μM in the buffer containing 20 mM Tris-HCl (pH 7.5), 0.5 M NaCl,
10 % (v/v) glycerol, 5 mM DTT (dithiothreitol). It was diluted to 0.5μM before AFM imaging with HEPES
buffer, which contained 20mM, HEPES (pH 7.5), 1mM MgCl2, 50mM NaCl, 10μM TCEP
(tris-2-carboxy-ethyl phosphine) 5 mM βME (β-mercaptoethanol). ΨRNA and TARpolyA RNA were
originally in the same HEPES buffer at a concentration of 74.18μM and 119μM, respectively. Both RNAs
need to be refolded before use. The protocol followed for refolding RNA was as follows. First, 22.2μL
74.18μM ΨRNA (or 13.8uL 119μM TARpolyA RNA) was added to a clean vial. Next, 2.5μL 1M(PH 7.5)
HEPES was added into the vial. Then, 20.3μL DEPC-H2O (or 28.7μL for TARpolyA RNA) was added. The
temperature of the mixture was then raised to 800C for 2 minutes, followed by 600C for another 2 minutes
using a water bath. Finally, 5μL 0.1M MgCl2 was added into the vial. Next, the mixture was kept at 370C
for 5 minutes followed by 00C with ice for 30 minutes. The RNA could then be used immediately or stored
at 40C for later use up to a week. After applying the refolding protocol, 30μM RNAs were diluted to 0.5μM
using the same HEPES buffer before AFM imaging. Brain PI(4,5)P2 purchased in powder form was
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obtained such that the final concentration of each component was 0.5μM.
2.3 Mica Substrates
Atomically smooth mica substrates were used in all AFM imaging experiments reported here. Mica
substrates with 1cm diameter were obtained from Ted Pella Inc. (Redding, CA, USA). The scotch tape
technique was used to obtain freshly cleaved surfaces used in all experiments. The surface roughness was
measured to be 0.1~0.2nm. The clean mica surface is negatively charged with charge density σ = -0.33C/m2
in air and σ = -2.5mC/m2 in water [41-43]. Therefore, freshly cleaved raw mica is a perfect substrate for
AFM imaging of HIV GagΔP6 because of its positive charge. However, as both ΨRNA and TARpolyA
RNA are negatively charged they cannot be observed directly on the raw mica substrate. To overcome the
repulsion between mica and RNAs, the mica surface was made positive by functionalization with APTES
(3-aminopropyltriethoxy silane). The procedure of preparing APTES-treated mica was as follows. First,
double-sided tape was used to stick a 10mm in diameter mica upon an AFM metal specimen disc with a
diameter of 15mm. Second, Scotch tape was used to cleave mica until the mica surface was complete and
flat. Then, 100μL APTES was added into a small plastic petri dish and put at the bottom of a desiccator
with a plastic net onto which the freshly cleaved mica was placed. The dessicator was next evacuated with
a mechanical vacuum pump. The vacuum suction was maintained for 30 minutes to allow APTES to
evaporate. APTES treated mica was ready to use immediately or can be stored in a covered petri dish for
later use. 30~50μL of the desired sample solution was next deposited on the freshly cleaved mica (or
APTES treated mica for RNAs) before AFM imaging .
2.4 AFM
Calibration of the AFM probes had to be done before imaging. The size of the AFM cantilever tip was
similar to that of the proteins or protein complexes studied. The comparable tip size will lead to feature
broadening, which is a common type of widely known convolution effect [44]. The major factors with
respect to the feature broadening are the pyramidal geometry and curvature radius of the tip. The AFM
probe used (HI’RES-C19/CR-AU, MikroMasch USA, Watsonville, CA, USA) was 125μm long and
22.5μm wide with a spring constant of 0.5N/m. it had a nominal resonant frequency of 65kHz in air and a
~32.36kHz in liquid. The special tips used had high aspect ratio and small tip radius. Nevertheless, the tip
size still had to be taken into account when analyzing the sizes of HIV GagΔP6, RNAs, lipids and their
mixed complexes. The calibration was done as follows. 2nm gold spheres were used to calibrate AFM
probes due to the comparability of the heights of HIV GagΔP6 and two RNAs. Because the measured
sample size also depends on the height of the sample, the actual tip size is given by equation (1) (see
Supplementary Material for more details):
λ = L – 1.46D (1)
Where λ is the actual diameter of the AFM cantilever tip, L is the measured size of the sample, and D is the
height of the sample. The effective tip diameter t for any sample is the difference between measured size of
the calibration standard sample and the height of the sample, as given by equation (2) (see Supplementary
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t = L – D = λ + 0.46D (2)
For the 2nm gold spheres, after fitting to a normal distribution, the mean measured size L = 7.56 ± 0.09nm,
the mean height D = 2.10 ± 0.02nm which is the actual diameter of the 2nm gold particle, as shown in Fig.2.
The total number of samples was 419 and the experiment was repeated twice. Therefore, the actual
diameter is λ = 4.5nm according to equation (1). The effective tip size for HIV GagΔP6 and other GagΔP6
complexes, including GagΔP6-ΨRNA, GagΔP6-PI(4,5)P2, PI(4,5)P2-ΨRNA-GagΔP6, is tGag = 5.4nm
given that the measured height of HIV GagΔP6 is 1.9nm according to equation (2). Similarly, the effective
tip size for ΨRNA and TARpolyA RNA is tRNA = 5.0nm given that the measured height of both RNAs is
1.1nm.
The AFM Nanoscope IIIa (Veeco Metrology, Santa Barbara, CA, USA) was used in tapping mode .
The procedure of the AFM operation in tapping mode in liquid environment is as follows [45]. First, a
freshly cleaved mica (or APTES treated mica for RNAs) was mounted on the AFM metal specimen holder
using double-sided tape. Next, a 30~50μL drop of following sample solutions used in the experiment was
deposited on the mica: (I) ΨRNA (0.5μM), (II) TARpolyA RNA (0.5μM), (III) GagΔP6 (0.5μM), (IV)
mixture of PI(4,5)P2-DPhPC-POPC (0.5μM : 5μM : 5μM) complex, (V) mixture of GagΔP6-ΨRNA
(0.5μM : 0.5μM) complex, (VI) mixture of GagΔP6-TARpolyA RNA (0.5μM : 0.5μM) complex, (VII)
mixture of GagΔP6-PI(4,5)P2 (0.5μM : 0.5μM) complex, (VIII) and mixture of PI(4,5)P2-ΨRNA-GagΔP6
(0.5μM : 0.5μM : 0.5μM) complex. Next the cantilever probe was mounted into the fluid cell. Care was
taken to make sure there are no bubbles. The tip is completely immersed in the solution. This is critical for
laser alignment when operating the AFM in a liquid environment. Next the laser signal was aligned and
then the piezo was oscillated through a range of frequencies till the resonance frequency was found. Next
the best resolution was obtained by adjusting the following scanning parameters: the vertical range,
samples/line, scan size, scan rate, integral gain, proportional gain and amplitude setpoint etc. Additional
checks were made after engaging the cantilever. During imaging the amplitude setpoint was adjusted such
that the trace and retrace lines were matched. The force exerted on the sample should be as small as
possible to prevent samples from being damaged. All the aforementioned parameters had to be adjusted
collectively to achieve the best resolution.
3 Results and Discussion
As RNAs have been well studied with the AFM [46-50], they were used to benchmark the experiments
reported here. The self-assembly of the CA domains in Gag and its mechanical properties have been
recently investigated on a mica substrate with the AFM [51]. The CA domain was
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the AFM experiments here, we started with size and morphology measurements of the RNAs (ΨRNA and
TARpolyA RNA) to benchmark and validate the measurement and analysis software developed.
Independent calibration of the measurement resolution was done using 2nm Au spheres as discussed above.
After confirmation of the validity of the technique we performed measurements on GagΔP6 and its
complexes with RNAs and PI(4,5)P2 lipid. The summary of the results is provided in Table 1. All the
experiments were repeated twice. Below we present the results from each individual experiment and also
discuss the effect of the RNA and PI(4,5)P2 lipid interaction with GagΔP6.
3.1 ΨRNA Size and Morphology Measurements
ΨRNA (0.5μM) being negatively charged was imaged on positively charged APTES treated mica.
Another motivation for measuring the ΨRNA by itself is to understand its individual morphology for future
comparison with that observed in the various GagΔP6 complexes. A typical AFM image of ΨRNA was
shown in Fig.3(a). In Fig.3(a), the AFM image of ΨRNA shows that most of ΨRNA molecules seem to
have inverted “L” shape. As shown in Fig.3 (b) and in Table 1, the mean height is 1.10 ± 0.01nm. This
height is in between the values 0.5nm, 2.5, 2.6nm found from double-stranded RNA [28,48,52] and similar
to 0.9~1.2nm that found by Hansma et al. [53]. The lateral size of the image was analyzed using specially
8developed software analysis (see Supplementary Material for more details). The statistics of the length
(longest dimension) and width (longest perpendicular dimension to the length) and height were plotted in
Fig. 3(b). As can be observed there are two distinct peaks for the length and similarly two distinct peaks for
the width. The three dimensional smooth histogram of the same length and width population distribution is
shown in Fig.3(c). Two distinct populations can be observed. The size of the first distribution with a mean
length of 17.9 ± 0.2nm and width 1.01 ± 0.02nm and height of 1.10 ± 0.01nm corresponds to the ΨRNA
monomer. The second peak with a mean length of 34.6 ± 0.3nm and width 3.8 ± 0.1nm and height of 1.10 ±
0.01nm corresponds to the ΨRNA dimer. Typical images of the monomer and dimers are enclosed in red
and green boxes respectively.
The expected size of the 109-nucleotide ΨRNA monomer can be calculated from the literature. RNAs
most commonly adopt either A-form or A'-form conformation [54, 55]. A-form RNA has 11 nucleotide per
helical pitch and A'-form has 12 nucleotide per helical pitch [55]. The rise per base pair for the A-form and
A'-form are 0.38nm and 0.27nm, respectively [56]. Given that most of ΨRNA nucleotides are self-paired
with each other as shown in Fig.1(b), ΨRNA should be double-stranded with 55 base pairs. This leads to a
length of 20.9nm and 14.9nm for the A-form and A'-form respectively. These values are consistent with the
mean measured monomer length 17.9nm. The width of ΨRNA monomer is 1.01 ± 0.02nm consistent with
the height of ΨRNA. For the monomer the width and heights will be the same as it is cylindrical in shape.
The mean measured length of ΨRNA dimer is 34.6 ± 0.3nm, which is approximately twice as long as that
of ΨRNA monomer. This means ΨRNA dimer consists of two ΨRNA monomers connecting head to head.
This assumption is reasonable given that DIS is located in the SL1 loop of ΨRNA as shown in Fig.1(b).
The width of ΨRNA dimer is roughly 3.8 ± 0.1nm that is much larger than two times the width of ΨRNA
monomer. This is probably because at the junction of two ΨRNA monomers the width is larger than
expected. Next the population distribution between monomers and dimers was analyzed. The length and
width histograms in Fig. 3(b) were fit to a normal distribution. Both histograms lead to a population
distribution of 74% monomer and 26% dimer respectively
3.2 TARpolyA RNA Size and Morphology Measurements
TARpolyA RNA (0.5μM) being negatively charged was also imaged on positively charged APTES
treated mica. Similar to ΨRNA, the motivation for measuring TARpolyA RNA by itself is to benchmark the
experiments and analysis protocol as well as understand its individual morphology for comparison with that
observed in the various GagΔP6 complexes. The observed typical AFM image of TARpolyA RNA in the
buffer solution is shown in Fig.4. In Fig.4(a), TARpolyA RNA image shows that most of TARpolyA RNA
molecules seem to have inverted “L” shape just like ΨRNA. Some examples are shown enclosed in red
boxes. The size distribution of the length (longest dimension), width (longest perpendicular dimension to
the length) and the height are shown in Fig. 4(b). As shown in Fig.4(b) and in Table 1, the mean height of
TARpolyA RNA is 1.10 ± 0.01nm. This height is consistent with that of ΨRNA and expectations from
structure. In Fig. 4(b) and (c) we observe only one peak in the length and width distributions. The mean
length of the TARpolyA RNA monomer is 17.1 ± 0.2nm. This value is slightly less than that of the ΨRNA
monomer observed earlier. Similar to ΨRNA, TARpolyA RNA should also be doubled-stranded as shown
in Fig.1(a). Thus the slightly smaller length of 0.8nm is reasonable from the 5 fewer nucleotides, given that
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width histogram distribution of TARpolyA RNA is 1.10 ± 0.05nm which is the same as the height and
consistent with the cylindrical structure for TARpolyA RNA. As the length and width distribution have only
one observable peak, it is concluded that the TARpolyA exists in solution predominantly as a monomer.
This is unlike that observed with ΨRNA where 26% dimers were found.
3.3 GagΔP6 Size and Morphology Measurements
The morphology of GagΔP6 (0.5μM), being net positive charge, was measured using the AFM on a
freshly negatively charged mica(-) substrate in solution. A typical AFM image is shown in Fig.5(a). The
motivation for measuring GagΔP6 is to serve as a control before addition of RNAs and lipids. Some
characteristics of common shapes observed were shown in red, green and blue boxes. In Fig.5(a), the AFM
image of GagΔP6 shows that most of GagΔP6 molecules have ellipsoidal shape rather than the expected
rod-like shape of the extended molecule.
As shown in Fig.5(b) and Table 1, the mean height is 1.93 ± 0.01nm which is consistent with the
expectation that the diameter of Gag is around 2~3nm as reported in Ref. [4]. The length and width of the
observed images are plotted in Fig.5(b). As observed three peaks were observed in the length distribution
but only two peaks in the width distribution. Normal distributions were fit to the length histogram to find
peak mean values of 10.3 ± 0.1nm, 20.0 ± 0.2nm and 29.0 ± 0.3nm. Similarly the mean values of the two
width distributions were found to be 6.2 ± 0.1nm and 12.9 ± 0.2nm respectively.
It might seem counterintuitive to have three peaks for length while having only two peaks for the
width. To have more insight, a three dimensional smooth histogram of the same length-width data was
plotted as shown in Fig.5(c). The shortest length and width distribution would correspond to that of the
monomer and the distribution with the next larger length would be expected to correspond to that of the
dimer. From Fig.5(c) the monomer and dimer have the same width. Thus in the width distribution
histogram they are represented together and correspond to the first peak at 6.2 ± 0.1nm. The statistical
analysis of the population also confirmed this assumption as the first peak of the width histogram is the
sum of monomer and dimer populations in the two peaks of the length histogram as given in Table 1. This
analysis was done by fitting each length and width peak to a normal distribution. From the length
distribution, the percentages of monomer, dimer, and tetramer are 59%, 35%, and 6%, respectively. The
population observed in the monomer and dimer from the length adds up to that observed in the first peak of
the width distribution.
Previous studies using hydrodynamic and neutron scattering measurements showed HIV GagΔP6 is
supposed to adopt a compact conformation such that MA and NC domains of GagΔP6 are close to each
other even though both of them are positively charged [3-5, 57]. The hydrodynamic radius, Rh, of GagΔP6
given by three different hydrodynamic tests are 3.6nm, 3.8nm, and 4.1nm, respectively. The radius of
gyraton, Rg, of GagΔP6 is best estimated to be 3.4nm from small angle neutron scattering (SANS). The Rg
of GagΔP6 when it is a 25nm straight rod is supposed to be 7.2nm [57]. The average Rg of GagΔP6 in
solution measured by SANS is also a monotonically increasing function of the GagΔP6 concentration, with
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maximum of Rg = 5nm at extremely high concentration, which means GagΔP6 molecules are in
monomer-dimer equilibrium [57].
Based on the AFM studies presented above, we can project approximate confirmations based on the
various lengths and widths of the populations observed. For the case of the monomer given a length of
10.3nm and width of 6.2nm a potential “C” like shape can be conjectured. This is consistent with the MA
domain being close to the NC domain as has been reported earlier for monomers in solution [4]. A
schematic of a potential monomer structure is shown in Fig.6. Based on the AFM measured dimensions of a
length of 20.0 nm and width of 6.2nm (same as monomer) a model of the GagΔP6 dimer would have two
monomers connecting back to back through their CA-CA interaction [4]. The CA-CA interaction leading
to dimerization has been reported in the literature [4]. The last population size distribution of GagΔP6 in
Fig.5 (c) has a length of 29.0nm and width is 12.9nm. This population from gel electrophoresis corresponds
to that of a tetramer (see Supplemental Material). From the measured size of the tetramers here, they could
be potentially formed by the interaction of two dimers.
3.4 GagΔP6-ΨRNA Complex Size, Morphology and Interaction
AFM measurements of the GagΔP6-ΨRNA (0.5μM : 0.5μM) complex were done on negatively
charged mica(-). The motivation for measuring GagΔP6-ΨRNA complex is to investigate the effect of
addition of specific ΨRNA to GagΔP6. According to current models the NC domain binds with ΨRNA and
this interaction is specific and is a critical step in the formation of HIV [22]. Fig.7(a) is a typical AFM
image of GagΔP6-ΨRNA complex. As shown in Fig.7(b), the mean height of GagΔP6-ΨRNA complex is
1.90 ± 0.01nm which is roughly the same as the height of just GagΔP6 discussed earlier. This height is
consistent with expectation given that the height of GagΔP6 and ΨRNA are 1.93nm and 1.10nm,
respectively. The length and width histograms of the complexes observed are shown in Fig.7(b). Similar to
GagΔP6, GagΔP6-ΨRNA also has three peaks for length and two peaks for width. Normal distributions
were fit to the length histogram to find peak mean values of 10.6 ± 0.2nm, 22.4 ± 0.1nm and 31.2 ± 0.2nm.
Similarly the mean values of the two width distributions were found to be 6.8 ± 0.1nm and 13.8 ± 0.1nm
respectively. The size of the length and widths are slightly larger than that found with only GagΔP6. This is
consistent with attachment of ΨRNA of around 1nm to the GagΔP6.
To understand the role of the ΨRNA addition the three-dimensional population distribution of the
length and width as shown in Fig.7(c) was analyzed. As with GagΔP6, three peaks corresponding to
monomer, dimer and tetramer complexes were observed. However the population distributions of the
monomer, dimer and tetramer are different for the GagΔP6- ΨRNA complex. Here we observed 35%
monomer, 49% dimers and 16% tetramers. In contrast with only GagΔP6 we observed 59% monomers 35%
dimers and 6% tetramers. The monomer decreased by 24%, the dimer increased by 14% and the tetramer
increased by 10%. Thus the addition of ΨRNA promotes multimerization of the GagΔP6 leading to higher
populations of dimers and tetramers.
The length of monomer remained roughly the same as prior to the addition of ΨRNA. The lengths of
dimer and tetramer were increased by about 2nm. The width increased by about 0.5nm~1nm for the
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monomer, dimer, and tetramer. This is consistent with the addition of ΨRNA of around 1nm to this
dimension. The most important conclusion of the effect of the addition of ΨRNA to GagΔP6 is that ΨRNA
can bind with GagΔP6 and facilitate GagΔP6 multimerization given the increases in percentages of dimer
and tetramer population.
3.5 GagΔP6-TARpolyA RNA Complex Size, Morphology and Interaction
GagΔP6-TARpolyA RNA (0.5μM : 0.5μM) complex was measured on a negatively charged
mica(-) surface. The motivation for measuring GagΔP6-TARpolyA RNA complex is to verify the effect of
the addition of non-specific TARpolyA RNA to GagΔP6 and compare it to the addition of specific ΨRNA
discussed above. Fig.8(a) is a typical AFM image of GagΔP6-TARpolyA RNA complex. As shown in
Fig.8(b), the mean height of GagΔP6-ΨRNA complex is 1.93 ± 0.01nm.
To understand the role of the TARPolyA RNA interaction with GagΔP6 the three dimensional
population distribution of the length and width as shown in Fig.8(c) was analyzed. As with GagΔP6, three
peaks corresponding to monomer, dimer and tetramer complexes were observed. However in contrast to the
case of the GagΔP6-ΨRNA complex in Fig.7(c) the population distribution of monomer, dimer and
tetramer are very similar to that of GagΔP6 alone observed in Fig.5(c). The sizes of GagΔP6-TARpolyA
RNA complex monomer, dimer and tetramer were found slightly larger than that of GagΔP6 alone. Thus
the addition of TARPolyA RNA might interact with GagΔP6 but does not promotes multimerization of the
GagΔP6 as observed with ΨRNA. These experiments were repeated and the results were always
reproducible. Webb et al. reported HIV Gag can bind with both ΨRNA and TARpolyA RNA but with
distinct binding mechanisms [22]. They proposed that HIV GagΔP6 binds with TARpolyA RNA through
both MA and NC domains whereas ΨRNA binds only through NC domain and leaves MA domain free to
later interact with the lipid membrane. Other studies also showed that HIV GagΔP6 can bind with both
ΨRNA and non-Ψ RNAs but the selective binding with ΨRNA is more energetically favorable than other
non-Ψ RNAs for HIV virus assembly [58-60]. The role of the RNA in multimerization of the Gag was not
addressed in these studies. The conclusion based on our data is that it is highly likely that HIV GagΔP6
interacts with ΨRNA and TARpolyA RNA through different mechanisms such that ΨRNA facilitates
GagΔP6 multimerization while TARpolyA RNA does not.
3.6 GagΔP6-PI(4,5)P2 Complex Size, Morphology and Interaction
The GagΔP6-PI(4,5)P2 (0.5μM : 0.5μM) complex was measured on negatively charged mica(-). The Gag
and lipid were diluted to 1μM before mixing. Then, equal amounts of Gag and lipid were mixed. The AFM
measurement was performed after the mixture was incubated for 3 hours.. A typical AFM image is shown
in Fig.9(a). The motivation for measuring GagΔP6-PI(4,5)P2 complex is to explore the effect of addition of
lipid PI(4,5)P2 to GagΔP6. The current understanding is that both MA and NC domains of Gag can bind to
PI(4,5)P2 through electrostatic forces.
As shown in Fig.9(b), the mean height of GagΔP6-PI(4,5)P2 complex is 1.93 ± 0.01nm that is
roughly the same as the height of just GagΔP6. This height is consistent with expectation given the small
size of PI(4,5)P2 in comparison to GagΔP6. The length and width histograms of the complexes observed
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are shown in Fig.9(b). Similar to GagΔP6, GagΔP6-PI(4,5)P2 also has three peaks for length and two peaks
for width. Normal distributions were fit to the length histogram to find peak mean values of 11.2 ± 0.1nm,
21.1 ± 0.1nm and 30.4 ± 0.2nm. Similarly the mean values of the two width distributions were found to be
6.7 ± 0.1nm and 14.0 ± 0.2nm respectively. The size of the length and widths are slightly larger than that
with only GagΔP6. In comparison to the GagΔP6-ΨRNA complex the GagΔP6-PI(4,5)P2 complex has
monomers of slighter larger length while the dimers and tetramers are of slightly smaller length.
To understand the role of PI(4,5)P2 addition to GagΔP6 the three dimensional population
distribution of the length and width as shown in Fig.9(c) was analyzed. As with GagΔP6, three peaks
corresponding to monomer, dimer and tetramer complexes were observed. However the population
distribution of monomer, dimer and tetramer are different from that observed with GagΔP6 alone or for the
GagΔP6- ΨRNA complex. Here we observed 47% monomer, 41% dimers and 12% tetramers. In contrast
with only GagΔP6 we observed 59% monomers 35% dimers and 6% tetramers and for the GagΔP6- ΨRNA
complex we observed 35% monomer, 49% dimers and 16% tetramers. Thus the addition of PI(4,5)P2
promotes multimerization of the GagΔP6. The increases in percentages of dimer and tetramer indicate that
PI(4,5)P2 can bind with GagΔP6 as reported in other studies using confocal microscopy, nuclear magnetic
resonance and equilibrium flotation assay [35, 40, 61-65]. But the increase in GagΔP6 multimerization with
the addition of PI(4,5)P2 is less than that observed with ΨRNA. The length and width of monomer, dimer,
tetramer all increased by about 1nm. This is probably because of the size of PI(4,5)P2 attached to the ends
of both MA and CA domains of HIV GagΔP6.
3.7 PI(4,5)P2-ΨRNA-GagΔP6 Complex Size, Morphology and Interaction
The PI(4,5)P2-ΨRNA-GagΔP6 (0.5μM : 0.5μM : 0.5μM) complex was measured on a negatively
charged mica(-). According to the prevailing model the lipid interacts with the MA domain of
GagΔP6-ΨRNA complex leading to a conformational change [22]. In these experiments to study the
PI(4,5)P2-ΨRNA-GagΔP6 complex, PI(4,5)P2 and ΨRNA were first mixed together in solution followed
by the addition of GagΔP6. This mixture was then used to measure the size and size distribution using the
AFM.
Fig.10(a) is a typical AFM image of PI(4,5)P2-ΨRNA-GagΔP6 complex. As shown in Fig.10(b),
the mean height of PI(4,5)P2-ΨRNA-GagΔP6 complex is 1.91 ± 0.01nm that is roughly the same as the
height of just GagΔP6. This height is consistent with expectation given that the height of GagΔP6 and
ΨRNA-GagΔP6 discussed earlier. The height of PI(4,5)P2 is much smaller by comparison. The length and
width histograms of the complexes observed are shown in Fig.10(b). In contrast to GagΔP6,
GagΔP6-ΨRNA and the GagΔP6- PI(4,5)P2 complexes there are only two peaks for length and two peaks
for width. Normal distributions were fit to the length histogram to find peak mean values of 10.9 ± 0.3nm,
and 23.8 ± 0.2nm. Similarly the mean values of the two width distributions were found to be 7.4 ± 0.2nm
and 22.1 ± 0.2nm respectively. In comparison to the binary complexes studied earlier the monomer length
is approximately similar, while the monomer width is slightly larger. For the dimer, the length is almost
60% larger than that of GagΔP6-ΨRNA and the GagΔP6- PI(4,5)P2 binary complexes .
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To understand the PI(4,5)P2-ΨRNA-GagΔP6 complex the three dimensional population
distribution of the length and width as shown in Fig.10(c) was analyzed. In contrast to all others above,
here the dimer and tetramer have the same length. The width of the tetramer is much larger than all
previous cases, increasing from 13-14nm to 22nm. Thus in the PI(4,5)P2-ΨRNA-GagΔP6 complex the
GagΔP6 undergoes a dramatic conformational change. This is consistent with the GagΔP6 MA and NC
domains moving further away from each other and taking on a rod-like confirmation. From the population
distribution in Fig.10(c), we observed 17% monomer, 51% dimers and 32% tetramers. In contrast, with
only GagΔP6 were we observed 59% monomers 35% dimers and 6% tetramers, the multimerization has
increased considerably. Comparing to the populations in the binary mixtures of ΨRNA-GagΔP6 and
PI(4,5)P2-GagΔP6 were we observed 35% and 47% monomer, 49% and 41% dimers and 16% and 12%
tetramers respectively, here in particular we observe much higher percentage of tetramers. Thus the
addition of PI(4,5)P2 along with ΨRNA promotes not only the dimerization of the GagΔP6 but in
particular the multimerization to tetramers and higher order complexes. In addition, the significant
change of the size indicates that GagΔP6 undergoes some conformational changes when both ΨRNA and
PI(4,5)P2 are present [38, 66]. Based on the sizes measured a schematic of the dimer and tetramer structure
is proposed in Fig.11. From the size of the tetramers the spacing between the GagΔP6 molecules is around
7 nm close to the value of 8nm reported in studies using cET [18,19]. The substantial increases in the
percentages of dimer and tetramer indicate that both ΨRNA and PI(4,5)P2 can bind with GagΔP6 and
collectively facilitate HIV GagΔP6 assembly as reported in other studies [57, 63].
4 Conclusion
The AFM technique was utilized to study the morphology of GagΔP6 (0.5μM), ΨRNA (0.5μM), and
their binding complexes with the lipid PI(4,5)P2 in HEPES buffer with 0.1 Å vertical and 1nm lateral
resolution. For the calibration 2nm diameter Au spheres were used. TARpolyA RNA was used as a negative
RNA control. The morphology of specific complexes GagΔP6-ΨRNA (0.5μM : 0.5μM),
GagΔP6-TARpolyA RNA (0.5μM : 0.5μM), GagΔP6-PI(4,5)P2 (0.5μM : 0.5μM) and PI(4,5)P2-ΨRNA-
GagΔP6 (0.5μM : 0.5μM : 0.5μM) were studied. They were imaged on either positively charged or
negatively charged mica substrates depending on the net charges carried by the respective materials. The
size and morphology of both ΨRNA and TARpolyA RNA measured was used to validate the technique in
comparison with literature. For the ΨRNA, from the measured size two distinct populations corresponding
to monomers and dimers were observed. In the case of TARpoly A RNA only the monomer population was
found for the concentrations studied. The morphology of GagΔP6, being net positively charged, was
measured using the AFM on a freshly cleaved negatively charged mica(-) substrate in HEPES solution with
a low salt concentration of 50mM NaCl. Three distinct size populations were found. They were found to
correspond to 59% monomer, 35% dimer and 6% tetramer form of GagΔP6. The presence of the multimers
was confirmed by gel electrophoresis. The addition of ΨRNA to 0.5μM GagΔP6 was observed to promote
multimerization of the GagΔP6 leading to higher populations of dimers (14% increase) and tetramers (10%
increase). The small change in size of the complexes confirmed the binding of the ΨRNA to GagΔP6.
The addition TARPolyA RNA to GagΔP6 did not modify the GagΔP6 population distribution of monomers,
dimers and tetramers. The interaction of PI(4,5)P2 with GagΔP6 complex was next measured on
negatively charged mica(-). From the population distribution of the monomers (47%), dimers (41%) and
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tetramers (12%), it was concluded that PI(4,5)P2 promotes multimerization of GagΔP6 but not to the extent
observed with ΨRNA.
The PI(4,5)P2-ΨRNA-GagΔP6 ternary complex was next studied using a negatively charged
mica(-) surface. Both the population and size distribution of the GagΔP6 was completely different from
that of the GagΔP6-ΨRNA and the GagΔP6- PI(4,5)P2 binary complexes. The population distribution of
the monomers (17%), dimers (51%) and tetramers (32%) was significantly different. Given the large
fraction of dimers and tetramers it was concluded that the presence of both PI(4,5)P2 and ΨRNA promotes
extensive multimerization of GagΔP6. In addition, the significant change of size indicates that GagΔP6
undergoes a conformational change to a 23.8nm rod like shape when both ΨRNA and PI(4,5)P2 are present.
From the size of the tetramers the spacing between the GagΔP6 molecules is around 7 nm which is
consistent with studies using cET in Ref [18, 19]. The substantial increases in the percentages of dimer
and tetramer indicate that both ΨRNA and PI(4,5)P2 can bind with GagΔP6 and collectively facilitate HIV
GagΔP6 assembly as reported using other techniques.
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Fig.1 HIV-1 genomic RNA partial sequence constructs used in this work. (a) TARpolyA RNA. (b) ΨRNA.
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Fig.2 AFM tip resolution calibration with 2nm diameter Au Sphere. (a) A typical AFM image of 2nm Au
sphere on mica in tapping mode in liquid. The scan size is 250nm×250nm. The height color bar scale is
2.5nm. (b) Histogram of 2nm diameter Au sphere for the measured size on the plane of the substrate (top)
and the measured height (bottom). Shown in red are normal distribution fits to the peaks. The mean
measured size on the plane of the substrate is 7.56 ± 0.09 nm, and the mean height is 2.10 ± 0.02nm. The
height is consistent with the sphere diameter. The size in the plane of the substrate reflects the role of the
tip size. Please see text and supplemental materials section for more details. The total number of samples
was 419 and the experiment was repeated twice.
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Fig.3 0.5μM ΨRNA on positively charged mica(+). (a) A typical AFM image with a scan size of
500nm×500nm. The height color bar scale is 2.0 nm. A few characteristic ΨRNAs are shown in boxes:
monomer (red) and dimer (green). (b) Histogram for length (left), width (middle), and height (right).
Shown in red are normal distribution fits to the peaks. (c) Three dimensional smooth histogram, where red
arrows indicate monomer and dimer. The mean height is 1.10 ± 0.01nm. The first peak with a mean length
of 17.9 ± 0.2nm and width 1.01 ± 0.02nm corresponds to the ΨRNA monomer. The second peak with a
mean length of 34.6 ± 0.3nm and width 3.8 ± 0.1nm corresponds to the ΨRNA dimer. The total number of
samples was 551 and the experiment was repeated twice.
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Fig.4 0.5μM TARpolyA RNA on positively charged mica(+). (a) AFM image with a scan size of
500nm×500nm. The height color bar scale is 2.0nm. A few characteristic TARpolyA RNAs are boxed in red.
(b) Histogram for length (left), width (middle), and height (right). Shown in red are normal distribution fits
to the peaks for length and height. Width is fit to a gamma distribution due to its non-negativity and
skewness. (c) Three dimensional smooth histogram, where the red arrow indicates the monomer
distribution. The peak corresponding to the TARpolyA RNA monomer has a mean length of 17.1 ± 0.2nm,
width of 1.10 ± 0.05nm and height of 1.10 ± 0.01nm. The total number of samples was 504 and the
experiment was repeated twice.
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Fig.5 0.5μM GagΔP6 on negatively charged mica(-). (a) A typical AFM image with a scan size of
500nm×500nm. The height color bar scale is 2.5nm. A few characteristic GagΔP6s are boxed: monomer
(red), dimer (green) and tetramer (blue). (b) Histograms for length (left), width (middle), and height (right).
Shown in red are normal distribution fits to the peaks. (c) Three dimensional smooth histogram, where red
arrows indicate the monomer, dimer, and tetramer distributions. The mean height is 1.93 ± 0.01nm for all
three. The first peak with a mean length of 10.3 ± 0.1nm and width 6.2 ± 0.1nm corresponds to the GagΔP6
monomer. The second peak with a mean length of 20.0 ± 0.2nm and width 6.2 ± 0.1nm corresponds to the
GagΔP6 dimer. The third peak with a mean length of 29.0 ± 0.3nm and width 12.9 ± 0.2nm corresponds to
the GagΔP6 tetramer. The total number of samples was 858 and the experiment was repeated twice.
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Fig.6 Rough model of the GagΔP6 monomer based on the measured mean values of the length and width.
MA domain is in red, CA domain is in yellow, and NC domain is in green.
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Fig.7 The mixture of GagΔP6-ΨRNA (0.5μM : 0.5μM) complex on negatively charged mica(-). (a) A
typical AFM image with a scan size of 500 nm×500 nm. The height color bar scale is 2.5nm. A few
characteristic GagΔP6-ΨRNA complexes are boxed: monomer (red), dimer (green) and tetramer (blue). (b)
Histogram for length (left), width (middle), and height (right). Shown in red are normal distribution fits to
the peaks. (c) Three dimensional smooth histogram, where red arrows indicate monomer, dimer, and
tetramer. The mean height is 1.90 ± 0.01nm for all three complexes. The first peak with a mean length of
10.6 ± 0.2nm and width 6.8 ± 0.1nm corresponds to the GagΔP6-ΨRNA monomer. The second peak with a
mean length of 22.4 ± 0.1nm and width 6.8 ± 0.1nm corresponds to the GagΔP6-ΨRNA dimer. The third
peak with a mean length of 31.2 ± 0.2nm and width 13.8 ± 0.1nm corresponds to the GagΔP6-ΨRNA
tetramer. The total number of samples was 895 and the experiment was repeated twice.
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Fig.8 Mixture of GagΔP6-TARpolyA RNA (0.5μM : 0.5μM) complex on negatively charged mica(-). (a) A
typical AFM image with a scan size of 500nm×500nm. The height color bar scale is 2.5nm. A few
characteristics TARpolyA RNA complexes are boxed: monomer (red), dimer (green) and tetramer (blue). (b)
Histogram for length (left), width (middle), and height (right). Shown in red are normal distribution fits to
the peaks. (c) Three dimensional smooth histogram, where monomer, dimer, and tetramer are indicated by
red arrows. The mean height is 1.93 ± 0.01nm for all three complexes. The first peak with a mean length of
10.8 ± 0.1nm and width 6.2 ± 0.1nm corresponds to the GagΔP6-TARpolyA RNA monomer. The second
peak with a mean length of 20.7 ± 0.2nm and width 6.2 ± 0.1nm corresponds to the GagΔP6-TARpolyA
RNA dimer. The third peak with a mean length of 29.9 ± 0.3nm and width 13.6 ± 0.2nm corresponds to the
GagΔP6-TARpolyA RNA tetramer. The total number of samples was 766 and the experiment was repeated
twice.
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Fig.9 Mixture of GagΔP6-PI(4,5)P2 (0.5μM : 0.5μM) complex on negatively charged mica(-). (a) A typical
AFM image with a scan size of 500nm×500nm. The height the color bar scale is 2.5nm. A few
characteristic GagΔP6-PI(4,5)P2 complexes are boxed: monomer (red), dimer (green) and tetramer (blue).
(b) Histogram for length (left), width (middle), and height (right). Shown in red are normal distribution fits
to the peaks. (c) Three dimensional smooth histogram, where monomer, dimer, and tetramer are indicated
by red arrows. The mean height is 1.93 ± 0.01nm for all complexes. The first peak with a mean length of
11.2 ± 0.1nm and width 6.7 ± 0.1nm corresponds to the GagΔP6-PI(4,5)P2 monomer. The second peak
with a mean length of 21.1 ± 0.1nm and width 6.7 ± 0.1nm corresponds to the GagΔP6-PI(4,5)P2 dimer.
The third peak with a mean length of 30.4 ± 0.2nm and width 14.0 ± 0.2nm corresponds to the
GagΔP6-PI(4,5)P2 tetramer. The total number of samples was 903 and the experiment was repeated twice.
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Fig.10 Mixture of PI(4,5)P2-ΨRNA-GagΔP6 (0.5μM : 0.5μM : 0.5μM) complex on negatively charged
mica(-). (a) A typical AFM image with a scan size of 500nm×500nm. The height color bar scale is 2.5nm. A
few characteristic PI(4,5)P2-ΨRNA-GagΔP6 complexes are boxed: monomer (red), dimer (green) and
tetramer (blue). (b) Histogram for length (left), width (middle), and height (right). Shown in red are normal
distribution fits to the peaks. (c) Three dimensional smooth histograms, where monomer, dimer, and
tetramer are indicated by red arrows. The mean height is 1.91 ± 0.01nm for all three complexes. The first
peak with a mean length of 10.9 ± 0.3nm and width 7.4 ± 0.1nm corresponds to the
PI(4,5)P2-ΨRNA-GagΔP6 monomer. The second peak with a mean length of 23.8 ± 0.2nm and width 7.4 ±
0.1nm corresponds to the PI(4,5)P2-ΨRNA-GagΔP6 dimer. The third peak with a mean length of 23.8 ±
0.2nm and width 22.1 ± 0.2nm corresponds to the PI(4,5)P2-ΨRNA-GagΔP6 tetramer. The total number of
samples was 616 and the experiment was repeated twice.
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Fig.11 Rough models of PI(4,5)P2-ΨRNA-GagΔP6 complexes based on the measured mean height and
width. (a) Dimer complex, (b) Tetramer complex. MA domain is in red, CA domain is in yellow, NC
domain is in green, ΨRNA is in cyan, and PI(4,5)P2 is in purple.
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Supplemental Material:
Investigation of HIV-1 Gag binding with RNAs and Lipids
by Atomic Force Microscopy
S1 AFM cantilever tip calibration
Au nanospheres of 2nm diameter were used for the calibration of the AFM cantilever tips. As
shown in Fig.S1(a), λ is the actual AFM cantilever tip size, L is the measured size of the calibration sample,
and D is the height of the same calibration sample. α and β are the effective front and back angles of the tip
which are related to the actual front angle FA and back angle BA of the tip FA through the tilt angle, θ, of
the AFM probe holder (fluid cell if imaging in liquid) as shown in Fig.S1(b).
Fig.S1 AFM tip calibration. (a) Schematic representation of the tip and a 2nm diameter Au calibration
sphere. The red curve is the trajectory of the tip when it scans from left to right. (b) The configuration of the
tip after it is placed into the AFM probe holder (fluid cell if imaging in liquid).
α = FA + θ
β = BA - θ
HN = λ
OP =
 
 
31
PS = OP sinβ
OS = OP cosβ
MQ = OS =
 
 
cosβ
NM = PM tanβ = (PS + SM) tanβ =
 
 
tanβ (sinβ + 1)
NQ = NM + MQ =
 
 
tanβ (sinβ + 1) +
 
 
cosβ =
 
 
(secβ + tanβ)
Similarly,
QZ =
 
 
(secα+ tanα)
L = HN + NQ + QZ = λ +
 
 
(secα+ tanα + secβ + tanβ)
For θ = 100, FA = BA = 200, then α = 300 and β = 100, hence,
L ≈ λ +1.46D
Therefore, the actual tip size is
λ = L – 1.46D (1)
And the effective tip size t for a sample with the height of D is
t = L – D = λ + 0.46D (2)
S2 Method for computation of the sample size
The size of the sample is computed by a MATLAB script. First, a proper threshold value is
selected to compute the height of the sample. The threshold value is so chosen to avoid the background
noise. The height is the distance from the highest point of the sample to the threshold value cutoff plane.
After the cutoff plane is set, the boundary of the sample can be obtained from the intersection of the sample
and the cutoff plane. The length of the sample is defined as the distance between the two furthest points on
the boundary. The width is defined as the distance between the two parallel lines restricting the object
perpendicular to the direction of the length defined above.
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Fig.S2 Schematic diagram of a sample with defined length and width.
S3 Gel electrophoresis
S3.1 Protocol for gel electrophoresis
SDS-PAGE usually comprises of acrylamide, bisacrylamide, SDS, and a buffer with the proper pH.
In the experiments reported here, tris-glycine SDS-PAGE was used with a 6% resolving gel and 5%
stacking gel. The exact composition used in the Tris-Glycine SDS-PAGE is given in Table S1. Here SDS is
sodium dodecyl sulfate, APS is ammonium persulfate, and TEMED is
N,N,N’,N’-tetramethylethylenediamine. In general, one SDS molecule is approximately bound to two
amino acids regardless of the polypeptide sequence. Therefore, the migration of SDS bound proteins is
proportional to the molecular weight of proteins. The procedure of SDS-PAGE gel electrophoresis used was
as follows. First, 10mL 6% resolving gel and 4mL 5% stacking gel were prepared based on the composition
for Tris-Glycine SDS-PAGE as given in Table S1. APS and TEMED were added later for the 5% stacking
gel. Then about 7mL of 6% resolving gel solution was added into the Mini-PROTEAN II Cell (BIO-RAD,
Hercules, CA, USA). Next 1mL isopropanol was added on top to remove air bubbles at the surface of the
resolving gel solution. After a wait of 20 minutes, the isopropanol was removed. Next, 40μL 10% APS and
4μL TEMED was added to the stacking gel solution. About 3mL of the 5% stacking gel solution was
placed above the resolving gel solution. Finally a 10-well Mini-Protein comb (BIO-RAD, Hercules, CA,
USA) was inserted on top of the stacking gel. The arrangement was allowed to form for 30 minutes before
proceeding.
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The sample solutions to be used were mixed with the dye bromophenol blue (Sigma-Aldrich,
Merck KGaA, Darmstadt, Germany) to the desired concentration. Then the sample solutions were boiled
for 5 minutes. Care was taken to seal all the sample solutions using parafilm. Next 1X SDS-PAGE
loading buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) was added into the gasket. The comb was
gently removed. The dyed sample solutions were added into each comb slot carefully. Enough 1X
SDS-PAGE loading buffer was added into the chamber that surrounded the gasket. It was confirmed that
bubbles were generated at the bottom of the gel electrophoresis equipment. The following settings V =
120V, I = 100mA, T = 75minutes, and K in “Volts” mode were used. The gel run was started and continued
until the color had almost reached the bottom. The equipment was disassembled to get the gel with the
distinct bands located at the different positions. A plastic wedge plate was used to cut the top part of the gel.
The gel was put into the transfer buffer (48 mM Tris, 39 mM glycine, 1.3mM SDS, 20%(v/v) methanol)
using a clean container and then placed on a rotator for 20 minutes. A piece of Amersham Hybond 0.45μm
PVDF blotting membrane (GE Healthcare Life Sciences, Pittsburgh, PA, USA) was cut to the same size as
the gel plate. A corner was cut to distinguish the orientation. Two pieces of the blot paper were soaked in
the transfer buffer for 20 minutes. The blotting membrane was soaked with pure methanol for 5 minutes.
Next the methanol was removed and the transfer buffer was added and allowed to soak for 20 minutes. The
blotting paper was placed on the semi-dry transfer cell. The blotting membrane was next positioned atop
the blotting paper followed by the gel plate. A second blotting paper was placed on top of the gel. Air
bubbles were removed by rolling a tube over the blotting paper. The following parameters V = 24V, I =
100mA, T = 28minutes, and K in “Volts” mode, were set to run the semi-dry transfer cell. Next 0.5g dry
milk was added to 10mL 1X Tris-buffered saline (TBS, 50 mM Tris-Cl, pH 7.5 150 mM NaCl) buffer to get
5% milk TBS. The blotting membrane was put into a clean container, and 5% milk TBS buffer was added
and incubated for 1 hour on a rocking platform in a freezer. The 5% milk TBS was then removed. Next
10mL reusable antibody (goat anti-HIV P24 in 5% milk TBS, 1:500) was added and incubated overnight on
a rocking platform in a freezer. The blotting membrane was washed 3 times with 1X TBS buffer with 10
min intervals. Next 10mL 5% milk TBS was prepared with the addition of 5μL of another antibody (rabbit
anti-goat secondary antibody). This was added into the blotting membrane and incubated for 90 minutes.
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The milk TBS was removed and the blotting membrane was washed 3 times with 1X TBS buffer. Enough
developing solution (10mL 1M Tris-HCl(pH 9.5), 2mL 5M NaCl, 0.5mL 1M MgCl2, 33μL 50mg/mL NBT
(nitro-blue tetrazolium chloride), and 16.5μL 50mg/mL BCIP (5-bromo-4-chloro-3'-indolyphosphate
p-toluidine salt) was added to completely cover the blotting membrane. After the bands appeared, the
blotting membrane was washed with 1X TAE (40mM Tris, 20mM acetic acid, and 1mM EDTA
(Ethylenediaminetetraacetic acid)) buffer. The blotting membrane was dried with nitrogen gas. A picture of
the blotting membrane was taken and then analyzed using the software ImagJ.
S3.2 Gel electrophoresis result
The motivation for implementing gel electrophoresis measurement was to confirm the identity of the
higher order multimer complexes found in the AFM measurements as corresponding to trimers or tetramers.
The results from Tris-Glycine SDS-PAGE is shown in Fig.S3. The 50kDa protein marker indicates the
bottom band corresponding to the 50kDa monomer. This is because the mass of the complete Gag
monomer is about 55kDa and that of GagΔP6 is around 50kDa [8]. The middle band is just above the
75kDa calibration marker and closely aligns with the 100kDa calibration marker, corresponding to that of
the Gag dimer as the mass of the GagΔP6 dimer should be 100kDa. The top band is in between the
calibration mark for 150kDa and 250kDa, which means they are tetramers with approximate molecular
weight of 200kDa for GagΔP6. For the Gag-ΨRNA complex the tetramer would have a mass around
236kDa if including one ΨRNA. These results confirmed that the complexes found in AFM measurements
were tetramers rather than trimers. As shown in Fig.S3(a) and (b), the percentages of dimer and tetramers
increased as the concentration of GagΔP6 increased from 0.5μM to 2μM. This result is consistent with the
conclusion that the average radius of gyration Rg of GagΔP6 in solution measured by SANS is a
monotonically increasing function of GagΔP6 concentration. This is reasonable because the size of the
tetramer is greater than the size of the dimer, which in turn is again greater than the size of the monomer
[57]. As shown in Fig.S3(b) and (c), or (a) and (d), the percentages of dimer and tetramers increased with
the addition of ΨRNA for the same concentration of GagΔP6. This was also confirmed in the AFM
measurements where ΨRNA can bind with GagΔP6 and facilitate GagΔP6 multimerization. As shown in
Fig.S3(c) and (f) and (g), the percentages of dimer and tetramers increased even more when both ΨRNA
and PI(4,5)P2 were added. Similar to ΨRNA, increasing PI(4,5)P2 lipid lead to increased GagΔP6
multimerization.
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Fig.S3 SDS-PAGE analysis (a) GagΔP6 (2μM). (b) GagΔP6 (0.5μM). (c) GagΔP6-ΨRNA (0.5μM : 0.5μM).
(d) GagΔP6-ΨRNA (0.5μM : 2μM). (e) GagΔP6-ΨRNA (2μM : 0.5μM). (f) PI(4,5)P2-ΨRNA-GagΔP6
(0.5μM : 0.5μM : 0.5μM). (g) PI(4,5)P2-ΨRNA-GagΔP6 (2μM : 0.5μM : 0.5μM). (h) 50kDa Protein
marker. (MW) Protein standards. The rightmost lane represents molecular weight of protein standards.
Bands corresponding to monomer, dimer, and tetramer are indicated on the left. Note: The standard proteins
bands beyond 100 kDa can be seen in the original gel but not in the Western blot since their large molecular
weight resulted in inefficient transfer to the membrane.
